T.A. Connors - Concepedia

Author

T.A. Connors

Also Known As

Connors, Thomas A., Richard J. Knox, T A Connors, T. A. CONNORS, T. A. Connors, T. Connors, T.A. CONNORS, T.A. Connors, THOMAS A. CONNORS, Thomas A. Connors

151

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

Institute of Cancer Research MRC Toxicology Unit Medical Research Council Inserm

About

T.A. Connors is an author at Institute of Cancer Research specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	50	2.5K
2	Biochemistry	16	22	1.1K
3	Natural Sciences	11	13	706
4	Engineering	3	3	77
5	Allergy	1	1	26

T.A. Connors

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamide T.A. Connors, Peter J. Cox, Peter B. Farmer, Biochemical Pharmacology Energy MetabolismBiochemistryMedicineCatabolismActive Intermediates	1974	344
New platinum complexes with anti-tumour activity T.A. Connors, Mark Jones, W. C. J. Ross, Chemico-Biological Interactions Inorganic ChemistryMedicinal ChemistryNatural SciencesCoordination ComplexMolecular Complex	1972	241
An athymic nude mutation in the rat Michael F. W. Festing, David Lovell, S. Sparrow, Nature Genetic DisorderGeneticsAthymic Nude MutationMolecular GeneticsReproductive Biology	1978	222
Structure and activity relationships of platinum complexes with anti-tumour activity P.D. Braddock, T.A. Connors, Mark Jones, Chemico-Biological Interactions Platinum ComplexesBiochemistryNatural SciencesCoordination ComplexMolecular Complex	1975	150
Cure of Mice bearing Advanced Plasma Cell Tumours with Aniline Mustard : the Relationship between Glucuronidase Activity and Tumour Sensitivity T.A. Connors, M. E. Whisson Nature Tumor BiologyOncogenic AgentMedicineImmunologyPathology	1966	140
2,4-Dinitro-5-ethyleneiminobenzamide (CB 1954): A potent and selective inhibitor of the growth of the Walker carcinoma 256 Loren Cobb, T.A. Connors, L. A. Elson, Biochemical Pharmacology Medicinal ChemistryWalker Carcinoma 256MedicineSelective InhibitorPharmacotherapy	1969	137
The choice of prodrugs for gene directed enzyme prodrug therapy of cancer. T.A. Connors PubMed	1995	129
Tumour inhibitory triazenes: Structural requirements for an active metabolite T.A. Connors, Phyllis M. Goddard, Kanti Merai, Biochemical Pharmacology MedicineOrganic ChemistryAnti-cancer AgentHeterocycle ChemistryPharmacology	1976	124
Studies on the mechanism of action of the tumour inhibitory triazenes R.C.S. Audette, T.A. Connors, H. George Mandel, Biochemical Pharmacology MedicineTumour Inhibitory TriazenesAnti-cancer AgentPharmacologyRadiation Oncology	1973	88
In vitro studies with hexamethylmelamine C.J. Rutty, T.A. Connors Biochemical Pharmacology MedicineTopical DrugVitro StudiesToxicologyPharmacology	1977	79

Page 1